| http://dbpedia.org/ontology/abstract
|
Il tucotuzumab celmoleukin è un farmaco an … Il tucotuzumab celmoleukin è un farmaco antitumorale; è un anticorpo monoclonale (tucotuzumab) unumanizzato e fuso con l'interleuchina-2 (celmoleukin). Il target d'azione è l'antigene , che è la molecola di adesione delle cellule epiteliali ai carcinomi, che si esprime in una grande varietà di cellule tumorali. Questo farmaco è sviluppato dalla .orali. Questo farmaco è sviluppato dalla .
, Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin). This drug was developed by EMD Pharmaceuticals.
|
| http://dbpedia.org/ontology/casNumber
|
339986-90-2
|
| http://dbpedia.org/ontology/fdaUniiCode
|
4ON7FF680U
|
| http://dbpedia.org/ontology/kegg
|
D09027
|
| http://dbpedia.org/ontology/wikiPageID
|
9686083
|
| http://dbpedia.org/ontology/wikiPageLength
|
1802
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1084075784
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Humanized_monoclonal_antibody +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Interleukin-2 +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/EpCAM +
, http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
, http://dbpedia.org/resource/EMD_Pharmaceuticals +
, http://dbpedia.org/resource/Fusion_protein +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
7812
|
| http://dbpedia.org/property/casNumber
|
339986
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
12124
|
| http://dbpedia.org/property/kegg
|
D09027
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/n
|
2044
|
| http://dbpedia.org/property/o
|
2408
|
| http://dbpedia.org/property/s
|
60
|
| http://dbpedia.org/property/source
|
zu/o
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/EpCAM +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
4
|
| http://dbpedia.org/property/verifiedrevid
|
450332018
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Keggcite +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Interleukin_receptor_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Tucotuzumab_celmoleukin?oldid=1084075784&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Tucotuzumab_celmoleukin +
|
| owl:sameAs |
https://global.dbpedia.org/id/3hV4x +
, http://it.dbpedia.org/resource/Tucotuzumab_celmoleukin +
, http://yago-knowledge.org/resource/Tucotuzumab_celmoleukin +
, http://dbpedia.org/resource/Tucotuzumab_celmoleukin +
, http://www.wikidata.org/entity/Q4000172 +
, http://rdf.freebase.com/ns/m.02pp34y +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodiesForTumors +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Antibody115027189 +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin). This drug was developed by EMD Pharmaceuticals.
, Il tucotuzumab celmoleukin è un farmaco an … Il tucotuzumab celmoleukin è un farmaco antitumorale; è un anticorpo monoclonale (tucotuzumab) unumanizzato e fuso con l'interleuchina-2 (celmoleukin). Il target d'azione è l'antigene , che è la molecola di adesione delle cellule epiteliali ai carcinomi, che si esprime in una grande varietà di cellule tumorali. Questo farmaco è sviluppato dalla .orali. Questo farmaco è sviluppato dalla .
|
| rdfs:label |
Tucotuzumab celmoleukin
|
